|
Sign In to gain access to subscriptions and/or personal tools.
|
Ecstasy: Are animal data consistent between species and can they translate to humans?
Neil Easton
Charles A. Marsden
School of Biomedical Science, University of Nottingham, Queen's Medical Centre, Nottingham, UK
The number of 3,4-methylenedioxymethamphetamine (ecstasy or MDMA) animal research articles is rapidly increasing and yet studies which place emphasis on the clinical signi.cance are limited due to a lack of reliable human data. MDMA produces an acute, rapid release of brain serotonin and dopamine in experimental animals and in the rat this is associated with increased locomotor activity and the serotonin behavioural syndrome in rats. MDMA causes dose-dependent hyperthermia, which is potentially fatal, in humans, primates and rodents. Subsequent serotonergic neurotoxicity has been demonstrated by biochemical and histological studies and is reported to last for months in rats and years in non-human primates. Relating human data to .ndings in animals is complicated by reports that MDMA exposure in mice produces selective long-term dopaminergic impairment with no effect on serotonin. This review compares data obtained from animal and human studies and examines the acute physiological, behavioural and biochemical effects of MDMA as well as the long-term behavioural effects together with serotonergic and dopaminergic impairments. Consideration is also given to the role of neurotoxic metabolites and the in.uence of age, sex and user groups on the long-term actions of MDMA.
Key Words: MDMA ecstasy metabolite human animal toxicity behaviour serotonin dopamine age
Journal of Psychopharmacology, Vol. 20, No. 2,
194-210 (2006)
DOI: 10.1177/0269881106061153

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. R. Meyer, F. T. Peters, and H. H. Maurer
The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine and Its Single Enantiomers
Drug Metab. Dispos.,
June 1, 2009;
37(6):
1152 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Selvaraj, R. Hoshi, Z. Bhagwagar, N. V. Murthy, R. Hinz, P. Cowen, H. V. Curran, and P. Grasby
Brain serotonin transporter binding in former users of MDMA ('ecstasy')
The British Journal of Psychiatry,
April 1, 2009;
194(4):
355 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Meyer, F. T. Peters, and H. H. Maurer
The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers
Drug Metab. Dispos.,
November 1, 2008;
36(11):
2345 - 2354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mueller, F. T. Peters, H. H. Maurer, U. D. McCann, and G. A. Ricaurte
Nonlinear Pharmacokinetics of ({+/-})3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") and Its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA That Develop After Typical Psychoactive Doses
J. Pharmacol. Exp. Ther.,
October 1, 2008;
327(1):
38 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. T. Peters, N. Samyn, T. Kraemer, W. J. Riedel, and H. H. Maurer
Negative-Ion Chemical Ionization Gas Chromatography-Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Cases
Clin. Chem.,
April 1, 2007;
53(4):
702 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott
Ecstasy versus alcohol: Tolstoy and the variations of unhappiness
J Psychopharmacol,
January 1, 2007;
21(1):
3 - 6.
[PDF]
|
 |
|
|
|